Article Versions Notes

Barbosa G, Gelves LGV, Costa CMX, Franco LS, de Lima JAL, Aparecida-Silva C, Teixeira JD, Mermelstein CdS, Barreiro EJ, Lima LM. Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs. Pharmaceuticals. 2022; 15(8):913. https://doi.org/10.3390/ph15080913

Barbosa, Gisele, Luis Gabriel Valdivieso Gelves, Caroline Marques Xavier Costa, Lucas Silva Franco, João Alberto Lins de Lima, Cristiane Aparecida-Silva, John Douglas Teixeira, Claudia dos Santos Mermelstein, Eliezer J. Barreiro, and Lidia Moreira Lima. 2022. "Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs" Pharmaceuticals 15, no. 8: 913. https://doi.org/10.3390/ph15080913

Barbosa, G., Gelves, L. G. V., Costa, C. M. X., Franco, L. S., de Lima, J. A. L., Aparecida-Silva, C., Teixeira, J. D., Mermelstein, C. d. S., Barreiro, E. J., & Lima, L. M. (2022). Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs. Pharmaceuticals, 15(8), 913. https://doi.org/10.3390/ph15080913